D.E. Shaw & Co’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-49,184
| Closed | -$152K | – | 3298 |
|
|
2023
Q3 | $152K | Sell |
49,184
-6,654
| -12% | -$20.6K | ﹤0.01% | 2622 |
|
|
2023
Q2 | $251K | Buy |
55,838
+8,589
| +18% | +$38.7K | ﹤0.01% | 2547 |
|
|
2023
Q1 | $269K | Sell |
47,249
-20,756
| -31% | -$118K | ﹤0.01% | 2709 |
|
|
2022
Q4 | $411K | Sell |
68,005
-10,876
| -14% | -$65.7K | ﹤0.01% | 2796 |
|
|
2022
Q3 | $521K | Sell |
78,881
-36,986
| -32% | -$244K | ﹤0.01% | 2858 |
|
|
2022
Q2 | $605K | Buy |
115,867
+92,256
| +391% | +$482K | ﹤0.01% | 2962 |
|
|
2022
Q1 | $163K | Buy |
+23,611
| New | +$163K | ﹤0.01% | 3675 |
|
|
2021
Q2 | – | Sell |
-12,546
| Closed | -$544K | – | 3714 |
|
|
2021
Q1 | $544K | Buy |
+12,546
| New | +$544K | ﹤0.01% | 2464 |
|